Sharps Compliance’s White Paper Explains the EPA’s New Hazardous Waste Pharmaceutical Rule – Is Your Facility Ready?


EPA’s New Pharmaceutical Rule – Takes Effect 08/21/19

The EPA’s recently finalized Pharmaceutical Rule is effective on August 21, 2019 – six months after being published in the Federal Register. This final rule, referred to as Subpart P, and titled Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine,” is a sector-based rule for the healthcare industry. Continue reading “EPA’s New Pharmaceutical Rule – Takes Effect 08/21/19”


EPA’s New Pharmaceutical Rule – Origin and Reason for the Rule

The Environmental Protection Agency’s (EPA) long-awaited final rule for managing hazardous waste pharmaceuticals generated by healthcare facilities was finalized and published in the Federal Register on February 22, 2019. This rule had its origins in the EPA’s 2008 Universal Waste proposal for pharmaceutical waste – and perhaps even earlier based on comments to the EPA from retailers.

Continue reading “EPA’s New Pharmaceutical Rule – Origin and Reason for the Rule”

Hazardous Drugs vs Hazardous Waste Pharmaceuticals

NIOSH vs RCRA

Are you confused by the terms “hazardous drug” and “hazardous waste pharmaceutical” (HWP)?  Well, you are not alone.  At first glance, it would appear they are the same, but they are not. Knowing the difference can save your facility money and potential regulatory citations. So, let’s clear the confusion.

Continue reading “Hazardous Drugs vs Hazardous Waste Pharmaceuticals”


Part 2: How New EPA Rule Will Affect Long-Term Care

In our last blog post, we discussed the Environmental Protection Agency’s (EPA) Proposed Rule on the Management Standards for Hazardous Waste Pharmaceuticals (HWP) This week’s post will examine how this regulation may affect long-term care facilities.

Continue reading “Part 2: How New EPA Rule Will Affect Long-Term Care”